Medimycetin 125mg / 5mL Suspension Filipinas - inglés - FDA (Food And Drug Administration)

medimycetin 125mg / 5ml suspension

mg prime pharma'l inc - chloramphenicol (as palmitate) - suspension - 125mg / 5ml

Clariva-250 250mg Tablet Filipinas - inglés - FDA (Food And Drug Administration)

clariva-250 250mg tablet

mg prime pharma'l inc - clarithromycin - tablet - 250mg

Salbumed 2mg Tablet Filipinas - inglés - FDA (Food And Drug Administration)

salbumed 2mg tablet

mg prime pharma'l inc - salbutamol (as sulfate) - tablet - 2mg

Macromed 200mg + 40mg / 5mL Suspension, oral Filipinas - inglés - FDA (Food And Drug Administration)

macromed 200mg + 40mg / 5ml suspension, oral

mg prime pharma'l inc - trimethoprim , sulfamethoxazole - suspension, oral - 200mg + 40mg / 5ml

PRIMENE 10% amino acids solution for injection Bottle Australia - inglés - Department of Health (Therapeutic Goods Administration)

primene 10% amino acids solution for injection bottle

baxter healthcare pty ltd - threonine, quantity: 3.7 mg/ml; proline, quantity: 3 mg/ml; glycine, quantity: 4 mg/ml; arginine, quantity: 8.4 mg/ml; tyrosine, quantity: 0.45 mg/ml; valine, quantity: 7.6 mg/ml; leucine, quantity: 10 mg/ml; serine, quantity: 4 mg/ml; isoleucine, quantity: 6.7 mg/ml; cysteine, quantity: 1.89 mg/ml; taurine, quantity: 0.6 mg/ml; lysine, quantity: 11 mg/ml; ornithine monohydrochloride, quantity: 3.18 mg/ml; histidine, quantity: 3.8 mg/ml; alanine, quantity: 8 mg/ml; aspartic acid, quantity: 6 mg/ml; methionine, quantity: 2.4 mg/ml; glutamic acid, quantity: 10 mg/ml; tryptophan, quantity: 2 mg/ml; phenylalanine, quantity: 4.2 mg/ml - injection, intravenous infusion - excipient ingredients: malic acid; water for injections - primene 10% amino acid iv infusion is indicated in infants and neonates at term or premature, for short-term use, of normal or low birth-weight when oral or enteral nutrition is impossible, insufficient or contraindicated. it is used as an amino acid component in a composite admixture of total parenteral nutrition.

CO-DIOVAN 80/12.5 mg/mg Film Coated Tablet Irlanda - inglés - HPRA (Health Products Regulatory Authority)

co-diovan 80/12.5 mg/mg film coated tablet

clear pharmacy - valsartan hydrochlorothiazide - film coated tablet - 80/12.5 mg/mg

CO-DIOVAN 160/12.5 mg/mg Film Coated Tablet Irlanda - inglés - HPRA (Health Products Regulatory Authority)

co-diovan 160/12.5 mg/mg film coated tablet

clear pharmacy - valsartan hydrochlorothiazide - film coated tablet - 160/12.5 mg/mg

CO-DIOVAN 160/12.5 mg/mg Film Coated Tablet Irlanda - inglés - HPRA (Health Products Regulatory Authority)

co-diovan 160/12.5 mg/mg film coated tablet

novartis pharmaceuticals uk ltd - valsartan, hydrochlorothiazide - film coated tablet - 160/12.5 mg/mg - angiotensin ii antagonists and diuretics

CO-DIOVAN 160/25 mg/mg Film Coated Tablet Irlanda - inglés - HPRA (Health Products Regulatory Authority)

co-diovan 160/25 mg/mg film coated tablet

novartis pharmaceuticals uk ltd - valsartan, hydrochlorothiazide - film coated tablet - 160/25 mg/mg - angiotensin ii antagonists and diuretics

CO-DIOVAN 320/12.5 mg/mg Film Coated Tablet Irlanda - inglés - HPRA (Health Products Regulatory Authority)

co-diovan 320/12.5 mg/mg film coated tablet

novartis pharmaceuticals uk ltd - valsartan, hydrochlorothiazide, micronized - film coated tablet - 320/12.5 mg/mg - angiotensin ii antagonists and diuretics